Press Releases
ROCKVILLE, Md. and BEIJING, Nov. 7, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces an exclusive distribution agreement with Pharmathen Global BV for the development and distributio
Read more...7 November 2019
TORONTO and LOS ANGELES, Nov. 7, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) and Aubrey Drake Graham ("Drake") are pleased to announce that they have entered into agreements to launch the More Life Growth CompanyTM, a fully licensed producer of ca
Read more...7 November 2019
BOSTON, Nov. 7, 2019 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the REVERSE-SD study of neflamapimod in earl
Read more...7 November 2019
BOSTON, Nov. 7, 2019 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the Division of Neurology Products of the U.S. Fo
Read more...7 November 2019
MADRID, Nov. 7, 2019 /PRNewswire/ -- Pharmactive Biotech Products, S.L., the maker of affron®, the clean-label saffron extract, has optimized product quality and concentration with AFF® ON Cool-Tech, its new, natural proprietary extraction proces
Read more...SAN JOSE, Calif., Nov. 7, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, to
Read more...7 November 2019
MINNEAPOLIS, Nov. 7, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 1:50 p.m. EST. The conference will be hel
Read more...7 November 2019
CARMIEL, Israel, Nov. 7, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced its third quarter 2019 fin
Read more...DUBLIN, Ohio, Nov. 7, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2020 revenue of $37.3 billion, an increase of 6 percent from the first quarter last year.
Read more...STAINES-UPON-THAMES, United Kingdom, Nov. 7, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced the p
Read more...